Extrahepatic Bile Duct Adenocarcinoma
1 clinical trials · Condition
◉ Watch Extrahepatic Bile Duct Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma (NCT01093222) | National Cancer Institute (NCI) | 2010-04-01 |
Track Extrahepatic Bile Duct Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.